Clinical trial
Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in…
NCT00334178 · Lotus Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00334178 |
|---|---|
| Title | Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine |
| Official title | A Multi-Center, Randomized, Parallel, Double-Blind, Placebo-Controlled Study in Evaluation the Efficacy and Safety of Laxymig® ER as Prophylactic Treatment in Patients With Migraine |
| Lead sponsor | Lotus Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine With Aura, Migraine Without Aura |
| Intervention type | Drug |
| Interventions | Laxymig ER (drug) |
| Enrollment | 74 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Jun 6, 2006 |
| Last update posted | Sep 10, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: